Viable Tumor Samples Market – Global Industry Analysis and Forecast (2023-2029)

Viable Tumor Samples Market is expected to grow at a CAGR of 3.52% during the forecast period. Viable Tumor Samples Market is expected to reach US$ 576.86 Mn. by 2029. The Global Viable Tumor Samples Market report is a comprehensive analysis of the industry, market, and key players. The report has covered the market by demand and supply-side by segments. The global Viable Tumor Samples report also provides trends by market segments, technology, and investment with a competitive landscape.

Viable Tumor Samples Market Overview:

Urbanization has resulted in a fast-paced life. Various factors like pollution, adulteration in food, and little to no time for exercise have resulted in the emergence of various diseases. The rise in Cancer, a deadly disease that affects organs to a damaging extent has created panic in people. The need to find a solution to this disease has resulted in the growth of viable tumor samples market. A Viable Tumor is defined as the presence of epithelial cells within a lymph node, tissues, or muscles with intact nuclear chromatin and cell structure. Viable Tumor Samples MarketTo know about the Research Methodology :- Request Free Sample Report A Tumor is the result of uncontrolled growth of cells and tissues in an organ, bone, or tissue. The presence of a tumor does not necessarily mean cancer but the presence of cancer is the result of the presence of a tumor. A sample of the tumor is extracted from an infected person to study, analyze, and find a solution for it. This has resulted in growth in the Viable Tumor Samples market. The rise in health-related concerns among people and the increased need to find a cure for deadly diseases have resulted in making the Viable Tumor Samples Market a preferable segment to enter.

Viable Tumor Samples Market Dynamics

Viable Tumor Samples are extracted and researched to find a cure for various health conditions. These are used in the healthcare sector to analyze, understand and cure diseases like cancer. Viable Tumor Samples are the whole sample which makes it easy for basic disease research and medicine development. Viable Tumor Samples are studied to find the origin and causes of various diseases related to immunity. This has made its application in Archeology and finding genetic origins. Viable Tumor Samples have numerous applications in research for diseases related to immunity, testing of new medicine, Oncology research, and physiological mechanism of diseases. With a wide range of applications from detecting to resolving a health-related issue, the Global Tumor Samples Market is growing.

Restraints:

Handling of apparatus involved requires skilled professionals limiting its use to too few people. The high Cost of Products and maintenance is the major restraining factor in this market. Regulatory Policies regarding the use and storage of Viable Tumor Sample vary from country to country. This has resulted in customization of product, increasing overall the cost. Change in policies is the reason which is limiting the growth of the Viable Tumor Sample Market.

Viable Tumor Samples Market Segment Analysis:

The Global Viable Tumor Market is segmented on the basis of, By Cancer type, this segment consists of types of cancer that are focused on in this method. Sub-segment consists of Lung Cancer, Prostate Cancer, Breast Cancer, Liver Cancer, Melanoma, which is a type of skin cancer, Lymphoma which affects the immunity system, Leukemia, which is a group of blood cancer, and research on Stem Cells. By Method of Storage, this segment consists of various methods used for the storage of viable tumors. Sub-Segments consist of Flash Frozen Tumor Samples. This technique provides preservation of Tumor Samples for more than 10 years. Fresh Tumor samples are Tumor samples extracted in recent time. Fresh extraction gives detailed Information of the sample without loss of Information. Dissociated Tumor cell Method consists of drawing conclusion based on similarity in nature of sample present. New methods like Formalin-Fixed and Paraffin-Embedded Method are known for fast and accurate extraction of samples than others. By End User, This segment consists of the use of Viable Tumor Samples by various sectors of the market. Sub-segments consist of the Pharmaceuticals Industry that uses this method for manufacturing medicines to cure people of various diseases. The Food & Beverages Industry uses viable tumor samples for improving the nutrient content of food products they are manufacturing. Semiconductors Industry uses viable tumor samples for manufacturing products related to the health sector. The medical devices manufacturing Industry uses Viable Tumor Samples for manufacturing various medical instruments used for treating people. Detection of diseases by using the Viable Samples method is used on a wide scale by Diagnostics Industry. The above pie-chart gives a clear idea regarding the use of Viable Tumor Sample by various sectors present in the market. It is observed that Pharmaceuticals Industry is the biggest user of this method. Viable Tumor Samples are used for manufacturing medicine to treat cancer and other dangerous diseases. This technique gives live samples of disease-struck tissues and membranes which give a clear idea regarding its cure. This sample has thus helped in finding medicine at a faster rate and with great accuracy. The Food & Beverages Industry is the second biggest user of this technique. To enhance the nutrient content of food products they are selling, this industry uses the Viable Tumor Samples technique for extraction of contents from various sources on large scale. Semiconductor Industry uses Viable Tumor Samples to study and develop various Gadgets related to human health. An increase in demand for products that have made tracking of health easy has resulted in increased use of Viable Tumor Samples in the Semiconductor Industry. The Medical Devices Industry uses Viable Tumor Samples to study and manufacture various types of medical equipment. An increase in diseases and a rise in awareness amongst people have resulted in growth in medical devices. The rise in demand has thus increased the market share of the medical devices industry in the Global Viable Tumor Samples market. Detection of various diseases by studying DNA structure gives accurate information regarding the disease and its affectivity. Diagnostics Industry uses Viable Tumor Samples for the detection of disease in the human body. Various other Industries use Viable Sample Tumor as per need and requirement.

Viable Tumor Samples Market Regional Insights:

The above image clarifies the presence of the Global Viable Tumor Samples Market across the world. It is observed that North America is the biggest market for the Global Viable Tumor Samples Market. Various factors like pollution, health-related concerns, increase in expenditure on medical research, and presence of advanced technology are some of the reasons behind it. The demand for medicines for many diseases is high in this region. This has resulted in finding generic alternatives for existing medicines. Existing customer base and rise in demand for advancements in medicine and technology have made North America the biggest market. Europe comes in second place. Here, factors are the same as in North America except for rising concern for pollution. An increase in the number of diseases has demanded more research to find a solution to various diseases. Asia-Pacific region stands in third place and is now increasing expenditure for research on finding medicines for various diseases. This has resulted in growth in the Asia-Pacific region. South America is showing growth but at a slow pace. Growth of Viable Tumor Samples Market is slow in The Middle East and Africa’s market reason for which is the presence of various restraining factors in this region. The objective of the report is to present a comprehensive analysis of the global Viable Tumor Samples market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the global market dynamics, structure by analyzing the market segments and Project the global market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the global market make the report investor’s guide.

Viable Tumor Samples Market Scope: Inquire before buying

Viable Tumor Samples Market
Report Coverage Details
Base Year: 2022 Forecast Period: 2023-2029
Historical Data: 2018 to 2022 Market Size in 2022: US $ 452.79 Mn.
Forecast Period 2023 to 2029 CAGR: 3.52% Market Size in 2029: US $ 576.86 Mn.
Segments Covered: by Cancer Type Lung Cancer Prostate Cancer Breast Cancer Liver Cancer Melanoma Lymphoma Leukemia Stem Cells
by Storage Method Flash Frozen Tumor Samples Fresh Tumor Samples Dissociated Tumor Cells Formalin-Fixed Paraffin Embedded Method Others
by End User Pharmaceuticals Industry Food & Beverages Industry Semiconductors Industry Medical Devices Industry Diagnostics Industry Others

Viable Tumor Samples Market, by Region:

North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America

Viable Tumor Samples Market Key Players:

1. StoreMyTumor 2. Cureline, Inc. 3. Conversant Bio 4. Fluxion Biosciences 5. Miltenyi Biotech 6. Crown Bioscience, Inc. 7. Indivumed GmbH 8. Ilumina, Inc. 9. QIAGEN NV 10. Neogenomics Laboratories, Inc. 11. HTG Molecular Diagnostics 12. Genomic Health, Inc. 13. Agilent 14. Thermo Fischer 15. BGI Genomics Co., Ltd. 16. Bruker Biosciences Corp. 17. Cepheid, Inc. 18. Promega Corporation 19. Applied Biosystems, Inc. 20. Natera Frequently Asked Questions: 1. Which region has the largest share in Global Viable Tumor Samples Market? Ans: North America region held the highest share in 2022. 2. What is the growth rate of Global Viable Tumor Samples Market? Ans: The Global Viable Tumor Samples Market is growing at a CAGR of 3.52% during forecasting period 2023-2029. 3. What is scope of the Global Viable Tumor Samples market report? Ans: Global Viable Tumor Samples Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Viable Tumor Samples market? Ans: The important key players in the Global Viable Tumor Samples Market are – StoreMyTumor, Cureline, Inc., Conversant Bio, Fluxion Biosciences, Miltenyi Biotech, Crown Bioscience, Inc., Indivumed GmbH, Ilumina, Inc., QIAGEN NV, Neogenomics Laboratories, Inc., 5. What is the study period of this market? Ans: The Global Viable Tumor Samples Market is studied from 2022 to 2029.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Viable Tumor Samples Market Size, by Market Value (US$ Bn.) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2022 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Viable Tumor Samples Market 3.4. Geographical Snapshot of the Viable Tumor Samples Market, By Manufacturer share 4. Global Viable Tumor Samples Market Overview, 2022-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Viable Tumor Samples Market 5. Supply Side and Demand Side Indicators 6. Global Viable Tumor Samples Market Analysis and Forecast, 2022-2029 6.1. Global Viable Tumor Samples Market Size & Y-o-Y Growth Analysis. 7. Global Viable Tumor Samples Market Analysis and Forecasts, 2022-2029 7.1. Market Size (Value) Estimates & Forecast By Cancer Type, 2022-2029 7.1.1. Lung Cancer 7.1.2. Prostate Cancer 7.1.3. Breast Cancer 7.1.4. Liver Cancer 7.1.5. Melanoma 7.1.6. Lymphoma 7.1.7. Leukemia 7.1.8. Stem Cells 7.2. Market Size (Value) Estimates & Forecast By Storage Method, 2022-2029 7.2.1. Flash Frozen Tumor Samples 7.2.2. Fresh Tumor Samples 7.2.3. Dissociated Tumor Cells 7.2.4. Formalin-Fixed 7.2.5. Paraffin Embedded Method 7.2.6. Others 7.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 7.3.1. Pharmaceuticals Industry 7.3.2. Food & Beverages Industry 7.3.3. Semiconductors Industry 7.3.4. Medical Devices Industry 7.3.5. Diagnostics Industry 7.3.6. Others 8. Global Viable Tumor Samples Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2022-2029 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Viable Tumor Samples Market Analysis and Forecasts, 2022-2029 9.1. Market Size (Value) Estimates & Forecast By Cancer Type, 2022-2029 9.1.1. Lung Cancer 9.1.2. Prostate Cancer 9.1.3. Breast Cancer 9.1.4. Liver Cancer 9.1.5. Melanoma 9.1.6. Lymphoma 9.1.7. Leukemia 9.1.8. Stem Cells 9.2. Market Size (Value) Estimates & Forecast By Storage Method, 2022-2029 9.2.1. Flash Frozen Tumor Samples 9.2.2. Fresh Tumor Samples 9.2.3. Dissociated Tumor Cells 9.2.4. Formalin-Fixed 9.2.5. Paraffin Embedded Method 9.2.6. Others 9.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 9.3.1. Pharmaceuticals Industry 9.3.2. Food & Beverages Industry 9.3.3. Semiconductors Industry 9.3.4. Medical Devices Industry 9.3.5. Diagnostics Industry 9.3.6. Others 10. North America Viable Tumor Samples Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Viable Tumor Samples Market Analysis and Forecasts, 2022-2029 11.1. Market Size (Value) Estimates & Forecast By Cancer Type, 2022-2029 11.2. Market Size (Value) Estimates & Forecast By Storage Method, 2022-2029 11.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 12. Canada Viable Tumor Samples Market Analysis and Forecasts, 2022-2029 12.1. Market Size (Value) Estimates & Forecast By Cancer Type, 2022-2029 12.2. Market Size (Value) Estimates & Forecast By Storage Method, 2022-2029 12.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 13. Mexico Viable Tumor Samples Market Analysis and Forecasts, 2022-2029 13.1. Market Size (Value) Estimates & Forecast By Cancer Type, 2022-2029 13.2. Market Size (Value) Estimates & Forecast By Storage Method, 2022-2029 13.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 14. Europe Viable Tumor Samples Market Analysis and Forecasts, 2022-2029 14.1. Market Size (Value) Estimates & Forecast By Cancer Type, 2022-2029 14.2. Market Size (Value) Estimates & Forecast By Storage Method, 2022-2029 14.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 15. Europe Viable Tumor Samples Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Viable Tumor Samples Market Analysis and Forecasts, 2022-2029 16.1. Market Size (Value) Estimates & Forecast By Cancer Type, 2022-2029 16.2. Market Size (Value) Estimates & Forecast By Storage Method, 2022-2029 16.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 17. France Viable Tumor Samples Market Analysis and Forecasts, 2022-2029 17.1. Market Size (Value) Estimates & Forecast By Cancer Type, 2022-2029 17.2. Market Size (Value) Estimates & Forecast By Storage Method, 2022-2029 17.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 18. Germany Viable Tumor Samples Market Analysis and Forecasts, 2022-2029 18.1. Market Size (Value) Estimates & Forecast By Cancer Type, 2022-2029 18.2. Market Size (Value) Estimates & Forecast By Storage Method, 2022-2029 18.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 19. Italy Viable Tumor Samples Market Analysis and Forecasts, 2022-2029 19.1. Market Size (Value) Estimates & Forecast By Cancer Type, 2022-2029 19.2. Market Size (Value) Estimates & Forecast By Storage Method, 2022-2029 19.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 20. Spain Viable Tumor Samples Market Analysis and Forecasts, 2022-2029 20.1. Market Size (Value) Estimates & Forecast By Cancer Type, 2022-2029 20.2. Market Size (Value) Estimates & Forecast By Storage Method, 2022-2029 20.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 21. Sweden Viable Tumor Samples Market Analysis and Forecasts, 2022-2029 21.1. Market Size (Value) Estimates & Forecast By Cancer Type, 2022-2029 21.2. Market Size (Value) Estimates & Forecast By Storage Method, 2022-2029 21.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 22. CIS Countries Viable Tumor Samples Market Analysis and Forecasts, 2022-2029 22.1. Market Size (Value) Estimates & Forecast By Cancer Type, 2022-2029 22.2. Market Size (Value) Estimates & Forecast By Storage Method, 2022-2029 22.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 23. Rest of Europe Viable Tumor Samples Market Analysis and Forecasts, 2022-2029 23.1. Market Size (Value) Estimates & Forecast By Cancer Type, 2022-2029 23.2. Market Size (Value) Estimates & Forecast By Storage Method, 2022-2029 23.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 24. Asia Pacific Viable Tumor Samples Market Analysis and Forecasts, 2022-2029 24.1. Market Size (Value) Estimates & Forecast By Cancer Type, 2022-2029 24.2. Market Size (Value) Estimates & Forecast By Storage Method, 2022-2029 24.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 25. Asia Pacific Viable Tumor Samples Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Viable Tumor Samples Market Analysis and Forecasts, 2022-2029 26.1. Market Size (Value) Estimates & Forecast By Cancer Type, 2022-2029 26.2. Market Size (Value) Estimates & Forecast By Storage Method, 2022-2029 26.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 27. India Viable Tumor Samples Market Analysis and Forecasts, 2022-2029 27.1. Market Size (Value) Estimates & Forecast By Cancer Type, 2022-2029 27.2. Market Size (Value) Estimates & Forecast By Storage Method, 2022-2029 27.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 28. Japan Viable Tumor Samples Market Analysis and Forecasts, 2022-2029 28.1. Market Size (Value) Estimates & Forecast By Cancer Type, 2022-2029 28.2. Market Size (Value) Estimates & Forecast By Storage Method, 2022-2029 28.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 29. South Korea Viable Tumor Samples Market Analysis and Forecasts, 2022-2029 29.1. Market Size (Value) Estimates & Forecast By Cancer Type, 2022-2029 29.2. Market Size (Value) Estimates & Forecast By Storage Method, 2022-2029 29.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 30. Australia Viable Tumor Samples Market Analysis and Forecasts, 2022-2029 30.1. Market Size (Value) Estimates & Forecast By Cancer Type, 2022-2029 30.2. Market Size (Value) Estimates & Forecast By Storage Method, 2022-2029 30.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 31. ASEAN Viable Tumor Samples Market Analysis and Forecasts, 2022-2029 31.1. Market Size (Value) Estimates & Forecast By Cancer Type, 2022-2029 31.2. Market Size (Value) Estimates & Forecast By Storage Method, 2022-2029 31.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 32. Rest of Asia Pacific Viable Tumor Samples Market Analysis and Forecasts, 2022-2029 32.1. Market Size (Value) Estimates & Forecast By Cancer Type, 2022-2029 32.2. Market Size (Value) Estimates & Forecast By Storage Method, 2022-2029 32.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 33. Middle East Africa Viable Tumor Samples Market Analysis and Forecasts, 2022-2029 33.1. Market Size (Value) Estimates & Forecast By Cancer Type, 2022-2029 33.2. Market Size (Value) Estimates & Forecast By Storage Method, 2022-2029 33.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 34. Middle East Africa Viable Tumor Samples Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Viable Tumor Samples Market Analysis and Forecasts, 2022-2029 35.1. Market Size (Value) Estimates & Forecast By Cancer Type, 2022-2029 35.2. Market Size (Value) Estimates & Forecast By Storage Method, 2022-2029 35.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 36. GCC Countries Viable Tumor Samples Market Analysis and Forecasts, 2022-2029 36.1. Market Size (Value) Estimates & Forecast By Cancer Type, 2022-2029 36.2. Market Size (Value) Estimates & Forecast By Storage Method, 2022-2029 36.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 37. Egypt Viable Tumor Samples Market Analysis and Forecasts, 2022-2029 37.1. Market Size (Value) Estimates & Forecast By Cancer Type, 2022-2029 37.2. Market Size (Value) Estimates & Forecast By Storage Method, 2022-2029 37.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 38. Nigeria Viable Tumor Samples Market Analysis and Forecasts, 2022-2029 38.1. Market Size (Value) Estimates & Forecast By Cancer Type, 2022-2029 38.2. Market Size (Value) Estimates & Forecast By Storage Method, 2022-2029 38.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 39. Rest of ME&A Viable Tumor Samples Market Analysis and Forecasts, 2022-2029 39.1. Market Size (Value) Estimates & Forecast By Cancer Type, 2022-2029 39.2. Market Size (Value) Estimates & Forecast By Storage Method, 2022-2029 39.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 40. South America Viable Tumor Samples Market Analysis and Forecasts, 2022-2029 40.1. Market Size (Value) Estimates & Forecast By Cancer Type, 2022-2029 40.2. Market Size (Value) Estimates & Forecast By Storage Method, 2022-2029 40.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 41. South America Viable Tumor Samples Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Viable Tumor Samples Market Analysis and Forecasts, 2022-2029 42.1. Market Size (Value) Estimates & Forecast By Cancer Type, 2022-2029 42.2. Market Size (Value) Estimates & Forecast By Storage Method, 2022-2029 42.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 43. Argentina Viable Tumor Samples Market Analysis and Forecasts, 2022-2029 43.1. Market Size (Value) Estimates & Forecast By Cancer Type, 2022-2029 43.2. Market Size (Value) Estimates & Forecast By Storage Method, 2022-2029 43.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 44. Rest of South America Viable Tumor Samples Market Analysis and Forecasts, 2022-2029 44.1. Market Size (Value) Estimates & Forecast By Cancer Type, 2022-2029 44.2. Market Size (Value) Estimates & Forecast By Storage Method, 2022-2029 44.3. Market Size (Value) Estimates & Forecast By End User, 2022-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Viable Tumor Samples Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. StoreMyTumor 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Cureline, Inc. 45.3.3. Conversant Bio 45.3.4. Fluxion Biosciences 45.3.5. Miltenyi Biotech 45.3.6. Crown Biosciences, Inc. 45.3.7. Indivumed GmbH 45.3.8. Ilumina, Inc. 45.3.9. QIAGEN NV 45.3.10. Neogenomics Laboratories, Inc. 45.3.11. HTG Molecular Diagnostics 45.3.12. Genomic Health, Inc. 45.3.13. Agilent 45.3.14. Thermo Fisher 45.3.15. BGI Genomics CO., Ltd. 45.3.16. Bruker Biosciences Corp. 45.3.17. Cepheid, Inc. 45.3.18. Promega Corporation 45.3.19. Applied Biosystems, Inc. 45.3.20. Natera 46. Primary Key Insights
  • INQUIRE BEFORE BUYING